EVH vs PFE · rev $646.5M vs P/E 20, rev $62.58B
Evolent Health Inc (EVH) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Evolent Health Inc (EVH) is a health information services company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported EVH revenue for 2024-12-31 was $646.5M. Net income was -$22.8M. Revenue was up 4.0% from 2024-09-30 to 2024-12-31. EVH currently screens at market cap $474.7M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
EVH currently screens at market cap $474.7M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the EVH and PFE stock pages for the full models.
Not investment advice.